National assessment procedure for medicines
Key Changes
- MHRA source titled National assessment procedure for medicines.
- Described as guidance on the MHRA's national assessment procedure for marketing authorisation applications.
- Supplied summary contains no effective date, binding requirements, or SaMD-specific details.
Affected Roles
None identified in supplied summary
Action Required
Original source must be reviewed before compliance decisions; suggest teams review the full MHRA guidance to confirm scope and lack of applicability to SaMD.